Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sirenas LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11330
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from nature’s chemistry. The company’s proprietary data mining technologyATLANTIS uses data mining and machine learningapproach to uncover the therapeutic potential of nature’s chemistry. Its pipeline products are used for sting pathway antagonist, t-cell activation, infectious disease and innate immunity. The company uses its pipeline products for immuno-oncology and infectious disease programs.It partners with pharmaceutical companies and research foundations to widen the use of its ATLANTI technology. Sirenas is headquartered in San Diego, California, the US.

Sirenas LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirenas LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sirenas LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sirenas LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sirenas Marine Raises Us$1.3 Million In Venture Financing 10
Partnerships 11
Sirenas Enters into Research Agreement wiith Bristol-Myers Squibb 11
Sirenas to Enter into Agreement with California Institute for Biomedical Research 12
Sirenas LLC – Key Competitors 13
Sirenas LLC – Key Employees 14
Sirenas LLC – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Dec 13, 2017: Sirenas Receives Research Grant Totaling $1.68 M To Accelerate Its Drug Discovery Technology, ATLANTIS 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Sirenas LLC, Pharmaceuticals & Healthcare, Key Facts 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirenas LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirenas LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Sirenas LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sirenas Marine Raises Us$1.3 Million In Venture Financing 10
Sirenas Enters into Research Agreement wiith Bristol-Myers Squibb 11
Sirenas to Enter into Agreement with California Institute for Biomedical Research 12
Sirenas LLC, Key Competitors 13
Sirenas LLC, Key Employees 14

List of Figures
Sirenas LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirenas LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gene Techno Science Co Ltd (4584)-製薬・医療分野:企業M&A・提携分析
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for cancer, intractable diseases and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-001 for immunological disease and oncology; GND-004, f …
  • J.M. Huber Corp:企業の戦略的SWOT分析
    J.M. Huber Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Daily Mail and General Trust plc:企業の戦略・SWOT・財務分析
    Daily Mail and General Trust plc - Strategy, SWOT and Corporate Finance Report Summary Daily Mail and General Trust plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Success Universe Group Limited:企業の戦略・SWOT・財務分析
    Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report Summary Success Universe Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Energia Argentina SA:電力:M&Aディール及び事業提携情報
    Summary Energia Argentina SA (ENARSA) is a state owned energy company that explores and exploits hydrocarbons in solid, liquid and gaseous states. It stores, transports, distributes, markets and industrializes the hydrocarbons and their derivatives. Energia conducts design, construction, commissioni …
  • Okinawa Electric Power Company Incorporated (9511):企業の財務・戦略的SWOT分析
    Okinawa Electric Power Company Incorporated (9511) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • InfraReDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary Infraredx Inc (Infraredx), a subsidiary of Nipro Corp, is a cardiovascular imaging solutions provider. The company offers Makoto Intravascular Imaging System, Dualpro IVUS and Dualpro IVUS NIRS. It offers intravascular imaging catheter. Infraredx operates travascular imaging catheter utilizi …
  • GOJO Industries Inc:企業の戦略・SWOT・財務情報
    GOJO Industries Inc - Strategy, SWOT and Corporate Finance Report Summary GOJO Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Perilya Limited:企業の戦略・SWOT・財務情報
    Perilya Limited - Strategy, SWOT and Corporate Finance Report Summary Perilya Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Alector LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Alector LLC (Alector) is a biotechnology company that develops therapies for immune system to cure neurodegeneration and cancer. The company discovers and develops immune modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. It combines state-of-the-art antibody …
  • Marston’s PLC:企業の戦略・SWOT・財務分析
    Marston's PLC - Strategy, SWOT and Corporate Finance Report Summary Marston's PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SeaBird Exploration PLC (SBX):石油・ガス:M&Aディール及び事業提携情報
    Summary SeaBird Exploration PLC (SeaBird) is an oil and gas company that offers marine seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, 4d repeat s …
  • TechnipFMC Plc (FTI):石油・ガス:M&Aディール及び事業提携情報
    Summary TechnipFMC plc (TechnipFMC) is a provider of oil and gas technologies, systems and services. The company focuses on subsea, surface technologies, onshore and offshore projects. Its portfolio of subsea services include drilling, asset management, installation of oil and gas field, remotely op …
  • Huaneng Power International Inc:企業の発電所・SWOT分析2018
    Huaneng Power International Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Alize Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alize Pharma SAS (Alize Pharma), a subsidiary of Jazz Pharmaceuticals Plc is a biotechnology company that discovers and develops proteins, biopharmaceutical drugs and peptides. The company provides unacylated ghrelin analog programs that develops stabilized peptide analog of unacylated ghrel …
  • Boardriders, Inc:企業の戦略的SWOT分析
    Boardriders, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Alternative Networks Plc:戦略・SWOT・企業財務分析
    Alternative Networks Plc - Strategy, SWOT and Corporate Finance Report Summary Alternative Networks Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Panoro Energy ASA (PEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Panoro Energy ASA (Panoro) is an independent oil and gas exploration and development company that explores, develops and produces oil and gas properties in Brazil and West Africa. The company holds interests in production and exploration assets in Santos and Camamu Almada basins in Brazil. I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆